Medipines
| Company type | Private |
|---|---|
| Industry | Medical equipment |
| Founded | 2013 |
| Headquarters | Orange County, California , United States |
| Products | AGM100 respiratory diagnostic device |
Medipines is a U.S.-based company specializing in medical equipment, headquartered in Orange County, California. It is recognized for its AGM100 device, an FDA-cleared respiratory diagnostic instrument designed to assess oxygen saturation and additional indicators to detect symptoms associated with the COVID-19. The AGM100 is implemented in medical institutions throughout the United States and Canada.
History
Established in 2013, Medipines created the AGM100 to enable quick, non-invasive evaluation of pulmonary gas exchange. The device was engineered in California and underwent testing at the University of British Columbia. It has since been integrated into respiratory monitoring protocols within Canadian healthcare facilities.
In July 2020, Medipines earned the National Consortium for Pediatric Device award in recognition of its innovative respiratory monitoring technology. By August 2021, the AGM100 had been included in the WHO Compendium, signifying its international acknowledgment in respiratory healthcare.